EUVIMEDEUVIMED entdecken
Crossref

Dicer inhibition delays wound closure by increasing Suz12 levels and regulating ITGAV levels in keratinocytes

Sushant Bhattacharya, Shruti Hazra, Malabika Datta iD

Journal of Molecular Endocrinology · 2025

DOI: 10.1530/jme-24-0122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Endocrinology, 2025. Verfasst von Sushant Bhattacharya und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Polycomb Repressive Complex 2, Ribonuclease III, Wound Healing, Keratinocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Delayed wound closure is a significant hallmark associated with diabetes. A previous study from our laboratory identified decreased levels of Dicer and miRNAs together with altered levels of wound-healing genes in the wounded tissues of diabetic rats. Comprehensive regulators of these wound-healing genes mapped onto the PRC2 (polycomb repressive complex 2) complex. Here, we show that Dicer inhibition increases the transcript levels of core components of the PRC2 complex, namely Suz12 (suppressor of zeste 12) and Ezh2 (enhancer of zeste 2), and of Mtf2 (metal response element-binding transcription factor 2), its additional subunit, and elevates H3K27me3 levels in HaCaT cells. Such patterns of increase were also observed in the wounded tissues of diabetic rats as compared to those of normal rats. In a scratch assay in HaCaT cells, while Dicer inhibition significantly prevented wound closure, this was rescued by Suz12 siRNA but not by Ezh2 inhibition, suggesting that Suz12 mediates the effects of Dicer siRNA in these cells. In addition, as compared to scramble-transfected cells, Dicer siRNA decreased the levels of integrin alpha V (Itgav), which is extensively implicated in the process of wound healing, and this effect was rescued in the presence of Suz12 siRNA. Itgav harbours potential histone methylation marks across the gene length, and Dicer inhibition, by increasing PRC2-mediated H3K27 methylation on Itgav, possibly decreases its transcription that subsequently impairs wound closure. These data put forth novel aspects of delayed wound closure as seen during diabetes and might be a potential target for therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycomb Repressive Complex 2Ribonuclease IIIWound HealingKeratinocytesDEAD-box RNA HelicasesAnimalsHumansEnhancer of Zeste Homolog 2 ProteinRatsHistonesMaleCell LineDiabetes Mellitus, ExperimentalGene Expression RegulationRNA, Small InterferingHaCaT CellsNeoplasm ProteinsTranscription Factors

Stichwörter der Autor:innen

DicerItgavPRC2diabetesimpaired wound healing

Substanzen

Polycomb Repressive Complex 2Ribonuclease IIIDEAD-box RNA HelicasesEnhancer of Zeste Homolog 2 ProteinSUZ12 protein, humanHistonesRNA, Small InterferingNeoplasm ProteinsTranscription Factors

Autor:innen und Institutionen

ORCID-Profile: Malabika Datta

Förderung

  • Council of Scientific and Industrial Research

Zitieren

APA

Bhattacharya, S., Hazra, S., & Datta, M. (2025). Dicer inhibition delays wound closure by increasing Suz12 levels and regulating ITGAV levels in keratinocytes. Journal of Molecular Endocrinology. https://doi.org/10.1530/jme-24-0122

Vancouver

Bhattacharya S, Hazra S, Datta M. Dicer inhibition delays wound closure by increasing Suz12 levels and regulating ITGAV levels in keratinocytes. Journal of Molecular Endocrinology. 2025. doi:10.1530/jme-24-0122

BibTeX
@article{Bhattacharya2025,
  author = {Bhattacharya, Sushant and Hazra, Shruti and Datta, Malabika},
  title = {Dicer inhibition delays wound closure by increasing Suz12 levels and regulating ITGAV levels in keratinocytes},
  journal = {Journal of Molecular Endocrinology},
  year = {2025},
  doi = {10.1530/jme-24-0122}
}
Kostenlos starten →